ARCHIVES

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

Pressure Builds On President To Sign Authorization Bill; No Movement Yet On Appropriations Measure

November 8, 1985

Pregnancy-Associated Breast Cancer More Likely Diagnosed At Advanced Stage

February 27, 2009

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

June 18, 2010

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

September 26, 1997

NCI Offers 200 Cell Lines to Scientist

May 6, 1983

Screening Concepts For Minority Women and Hispanics Approved

May 26, 1989